La revascularización incompleta no tiene el mismo significado en todos los pacientes

Incomplete Revascularization Does Not Mean the Same Thing for All Patients

Several studies show that patients with multivessel lesions who undergo angioplasty with incomplete revascularization experience more events, including higher mortality, than a cohort of patients who have undergone complete revascularization. In most cases, the analysis was dichotomic (complete vs. incomplete revascularization), but more recent studies show that there may be a gradient, a continuum, in<a href="https://solaci.org/en/2018/02/14/incomplete-revascularization-does-not-mean-the-same-thing-for-all-patients/" title="Read more" >...</a>

El estudio CULPRIT-SHOCK finalmente se publica en el NEJM y llega para cambiar las guías

The CULPRIT-SHOCK Study Is Finally Published in NEJM and It Is Bound to Change Guidelines

During SOLACI’s coverage of the TCT 2017 Congress in Denver, Colorado, we already mentioned some of the outcomes of this study that has arrived to revolutionize clinical practice, given the differences between its results and those of the classic SHOCK trial, which has marked for almost 20 years the treatment strategy for patients with infarction complicated<a href="https://solaci.org/en/2018/02/09/the-culprit-shock-study-is-finally-published-in-nejm-and-it-is-bound-to-change-guidelines/" title="Read more" >...</a>

¿Se justifica utilizar filtro de protección distal en los puentes venosos?

It is justified to use distal protection filter in venous bridges?

The current guidelines point out a class I recommendation to the use of distal embolic protection devices for angioplasty in venous bridges, in fact, the evidence is controversial to support this recommendation. The goal of this meta-analysis was to compare mortality from any cause, major cardiovascular events, acute myocardial infarction, and target vessel revascularization of<a href="https://solaci.org/en/2018/02/07/it-is-justified-to-use-distal-protection-filter-in-venous-bridges/" title="Read more" >...</a>

These were the 5 most read scientific articles of January

1) The 10 Commandments of ESC’s New STEMI Guidelines The authors have given an entertaining account of the most relevant points and differences between the new STEMI guidelines and the prior ones, from 2014. Read more 2) Burnout Syndrome among Cardiologists For the first time, the American College of Cardiology (ACC) has carried out a survey on this phenomenon,<a href="https://solaci.org/en/2018/02/01/these-were-the-5-most-read-scientific-articles-of-january/" title="Read more" >...</a>

La importancia de saber qué conductos va a utilizar el cirujano para revascularizar a mi paciente

The Importance of Knowing Which Conduits Will a Surgeon Use for Revascularization

Whether a second arterial conduit improves outcomes in patients undergoing myocardial revascularization surgery is and will remain unclear until the 10-year results of the ART (Arterial Revascularization Trial) are published. Consequently, arterial conduits other than the left internal thoracic artery are seldom used in daily practice. Using a database including 126 non-federal hospitals in California, researchers<a href="https://solaci.org/en/2018/01/30/the-importance-of-knowing-which-conduits-will-a-surgeon-use-for-revascularization/" title="Read more" >...</a>

Disnea y oclusiones totales crónicas: un síntoma que podemos aliviar (o al menos intentarlo)

Dyspnea and Chronic Total Occlusion: A Symptom That We Can (Attempt to) Improve

Dyspnea is one of the most challenging symptoms as regards its assessment and treatment in patients with coronary disease, since it may stem from both cardiac and non-cardiac causes. Patients in whom dyspnea is the sole symptom of coronary disease are at a higher risk of not receiving adequate treatment, and their short- and long-term<a href="https://solaci.org/en/2018/01/26/dyspnea-and-chronic-total-occlusion-a-symptom-that-we-can-attempt-to-improve/" title="Read more" >...</a>

Seguimiento con OCT de las erosiones de placa con tratamiento médico y sin stent

OCT Follow-Up of Plaque Erosion with Medical Therapy and Without Stenting

Most acute coronary syndromes (ACS) are caused by the following three different pathologies: Plaque rupture Plaque erosion Calcified nodule In daily clinical practice, all patients who experience them are treated with angioplasty, regardless of which of these physiopathologies led to the ACS in each case. Some early reports indicate that patients with plaque erosion might<a href="https://solaci.org/en/2018/01/25/oct-follow-up-of-plaque-erosion-with-medical-therapy-and-without-stenting/" title="Read more" >...</a>

The 9 most read scientific articles of 2017 in interventional cardiology

1) New High Blood Pressure Guidelines The wait is finally over: the high blood pressure guidelines that have been in the works for the past 3 years saw the light of day at the American Heart Association (AHA) 2017 Scientific Sessions. Read more 2) Nearly half of interventional cardiologists may have pre-cataract lesions This statement is based on eye<a href="https://solaci.org/en/2018/01/23/the-9-most-read-scientific-articles-of-2017-in-interventional-cardiology/" title="Read more" >...</a>

Does a Combination of Diabetes and Acute Coronary Syndrome Change the Revascularization Strategy?

The results of the FREEDOM (Future Revascularization Evaluation in Patients With Diabetes Mellitus: Optimal Management of Multi-vessel Disease) trial have shown a lower rate of events in patients with diabetes and stable multivessel disease who were randomized to undergo myocardial revascularization surgery, compared to those who underwent angioplasty. Surgery even showed a mortality reduction that<a href="https://solaci.org/en/2018/01/22/does-a-combination-of-diabetes-and-acute-coronary-syndrome-change-the-revascularization-strategy/" title="Read more" >...</a>

DEFINE FLAIR and IFR SWEDEHEART: Safety in Revascularization Based on FFR and iFR in Both Stable and ACS Patients

What Is the Long-Term Outcome of Lesions Deferred Using FFR/iFR?

The presence of inducible ischemia is an essential prerequisite to obtain clinical benefits from revascularization through angioplasty. In that sense, the measurement of fractional flow reserve (FFR) is the gold standard as regards invasive methods assessing the functional significance of epicardial artery stenosis. As opposed to FFR, the measurement of the instantaneous wave-free ratio (iFR)<a href="https://solaci.org/en/2018/01/18/what-is-the-long-term-outcome-of-lesions-deferred-using-ffr-ifr/" title="Read more" >...</a>

Angioplasty